药物开发 药物开发
Guillaume Blivet1, Hugo Cavadore2, Marwan N Sabbagh3
1REGEnLIFE, Montpellier, France.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
光生物调制 (PBM) 是一种安全的,非侵入性的治疗方法,对阿尔茨海默氏症 (AD) 有希望. 需要进一步的高质量研究来证实它的有效性,并建立标准化的临床使用协议.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 的病理生理学包括蛋白质病变,氧化应激,神经炎症和脑肠轴失调.
- 光生物调制 (PBM) 使用低水平光疗作为AD的非侵入性治疗方法.
- 临床前PBM研究表明,它可以减少氧化应激,炎症,并增强神经发生.
研究的目的:
- 批判性地评估目前关于治疗AD的PBM治疗的临床证据.
- 评估PBM在AD治疗中的治疗潜力和可行性.
- 探索PBM在AD的组合治疗策略中的作用.
主要方法:
- 自2017年以来发表的八项临床研究的系统审查.
- 包括双盲,单盲和开放的随机对照试验 (RCT).
- 研究涉及患有AD,痴呆症或轻度认知障碍 (MCI) 的患者.
主要成果:
- 总是证明PBM对AD和相关痴呆症是安全的.
- 初步证据表明,从PBM治疗中获得潜在的认知益处.
- 由于样本规模小和方法异质性有限,证据有限,需要进一步研究.
结论:
- 作为一种安全的,非侵入性的AD治疗方法,PBM疗法具有显著的前景.
- 广泛的临床应用需要严格的疗效验证和标准化的协议.
- 未来的高质量研究对于将PBM确立为AD的主流治疗选择至关重要.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
446
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
269
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
269
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
